A carregar...
Inclisiran: A New Promising Agent in the Management of Hypercholesterolemia
The discovery of proprotein convertase subtilisin-kexin type 9 (PCSK9), a serine protease which binds to the low-density lipoprotein (LDL) receptors and targets the receptors for lysosomal degradation, offered an additional route through which plasma LDL-cholesterol (LDL-C) levels can be controlled....
Na minha lista:
| Publicado no: | Diseases |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6163360/ https://ncbi.nlm.nih.gov/pubmed/30011788 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diseases6030063 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|